China BioPharma Ltd.

Zhongtian Dasha 16-L
173 Yugu Road
Hangzhou
ZHJ 310007
China

Email: info@ChinaBiopharma.com.cn

Show jobs for this employer

About China BioPharma Ltd.

China Biopharma Inc. (CBI) is a provider of pharmaceutical products with its focus mainly on the introduction and marketing of human vaccines and other pharmaceutical products. It has established its distribution and development platform in China and as a result of its acquisition of interest in its majority owned subsidiary, Hainan CITIC Bio-pharmaceutical Development Co., Ltd. (HCBD) and, as a result of its joint venture with Zhejiang Tianyuan Bio-pharmaceutical Co., Ltd. (Zhejiang Tianyuan). It has two operational segments. One segment, consisting of CBL and its subsidiaries provides bio-pharmaceutical products. The other segment, which consists of China Quantum Communication Limited (CQCL) and its subsidiary, was engaged in the business of providing telecommunications services and developing related technology. However, following its re-positioning of its business focus from telecommunications to pharmaceutical operations, CQCL ceased carrying on any daily business activities.